Jodi Parsons, PhD
VP, Regulatory AffairsDr. Parsons is our Vice President of Regulatory Affairs.
She brings 30 years of experience in global pharmaceutical development of oligonucleotides, small molecule drugs and biologics. Prior to joining Oruka, she established and led the regulatory functions at Escient Pharmaceuticals, Longboard Pharmaceuticals and Dart NeuroScience, where she implemented global regulatory strategies for development of therapeutics targeting neurosensory-inflammatory, rare neurological, and neurodegenerative disorders. At Xencor, she led regulatory initiatives for the dual checkpoint inhibitor immuno-oncology program. Earlier in her career, she held senior regulatory/project leadership roles at Somaxon, Elan, and Ionis contributing to the successful development and registration of products such as Silenor® for insomnia, Tysabri® for MS and Crohn’s disease, and Vitravene® for CMV retinitis.
Dr. Parsons earned her PhD in Chemistry from Emory University.